Tickerplace logo

Tickerplace

Cynata Therapeutics Limited logo

CYPCynata Therapeutics Limited

CYP Stock Price, Valuation & Chart | Cynata Therapeutics Limited

Compare
$0.010+0.00 (+0.00%)

At close · 02 Sept 2026, 04:20 am

Sector: HealthcareCYP intrinsic valueCYP calculated fair value vs priceWebsite
OverviewFinancialsDividendsRatios

CYP Historical price chart

CYP Key Stats

Fair Value
Disclaimer

Disclaimer: This fair value estimate is for informational purposes only and should not be considered as investment advice. Fair value calculations are based on DCF (Discounted Cash Flow), P/E Multiple, and P/S Multiple models and assumptions that may not reflect actual market conditions. Always conduct your own research and consult with a financial advisor before making investment decisions.

Unlock
Market Capitalization2.68M
PE Ratio-0.3
EPS-0.04
Trading Volume292.04K
Today's High/Low0.01/0.01
Dividend Yield0.00
52 Week High/Low0.43/0.01
Shares Outstanding243.45M
CYP Financial Statement

CYP Analyst ratings

Buy

Strong buy
1
Buy
0
Hold
0
Sell
0
Strong sell
0

Based on 1 analyst giving stock ratings to CYP in the past 3 months.

CYP Analysis & performance metrics

CYP Company profile

Cynata Therapeutics Limited, together with its subsidiaries, develops and commercializes a proprietary mesenchymal stem cell technology under the Cymerus brand for human…

CYP Management team

Management
Peter Gordon Webse B.Bus, FCIS, FCPA, FGIA, M.A.I.C.D.
Company Secretary
Kilian KellyCEO
MD, Chief Executive Officer & Director
Mathias Kroll
Chief Business Officer
Jolanta Airey
Chief Medical Officer
Total 4 executives

CYP Frequently asked questions

What is Cynata Therapeutics Limited (CYP) Stock Price?

Current stock price of Cynata Therapeutics Limited (CYP) stock is $0.010. The stock price is +0.00% higher in the session. The intraday range can be seen from this page. Volume of Cynata Therapeutics Limited (CYP) stock is 292.04K.

Last updated at 02 Sept 2026, 04:20 am.

Why is the Cynata Therapeutics Limited (CYP) stock price going up or down today?

The stock price of Cynata Therapeutics Limited (CYP) can change with earnings, company news, and overall market sentiment. Cynata Therapeutics Limited operates in the Healthcare / Unknown market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.

Is the Cynata Therapeutics Limited stock expensive at its current price?

Whether Cynata Therapeutics Limited looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for CYP on this page is -0.30. EPS on this page is -0.04. Compare those figures with peers and growth expectations before deciding if the current Cynata Therapeutics Limited price is justified.

How has the stock price of Cynata Therapeutics Limited (CYP) performed historically?

Historical performance for Cynata Therapeutics Limited (CYP) is shown on the price chart on this page. Review multi-period moves alongside volume to see how CYP reacted to past earnings and market events.

Should I buy Cynata Therapeutics Limited (CYP) stock, at this price?

Buying Cynata Therapeutics Limited (CYP) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.